Drug Type saRNAs |
Synonyms RAG-06 |
Target |
Action stimulants |
Mechanism SMN2 stimulants(Survival motor neuron protein stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Spinal Muscular Atrophy | Preclinical | China | 28 Feb 2022 |





